This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
The products are slated to be manufactured at the Ankleshwar facility and is expected to start contributing meaningfully to the revenue from FY25
The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene
Reports revenue growth of 9% to INR 882 crores in Q2 FY24
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
Subscribe To Our Newsletter & Stay Updated
